| Serial Number | 97052171 |
| Word Mark | NEOFORDEX |
| Filing Date | Wednesday, September 29, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 1, 2022 |
| Registration Number | 6888402 |
| Registration Date | Tuesday, November 1, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 16, 2022 |
| Goods and Services | Pharmaceutical and veterinary products for treating progression of chronic diseases, proliferative diseases, and for treating rheumatological diseases; pharmaceutical and veterinary products for treating oncological diseases, namely, colon cancer, rectum cancer, breast cancer, prostate cancer, pancreatic cancer, gastric cancer, thyroid cancer, larynx cancer, liver cancer, uterine cancer, cervical cancer, esophagus cancer, ovarian cancer, lung cancer, pleural cancer, oral cavity cancer, kidney cancer, bladder cancer, testicular cancer, melanoma, lymphatic cancer, hematopoietic cancer, carcinoma, sarcoma, nervous system cancer, namely, primary tumors; pharmaceutical and veterinary products for treating onco-haematological diseases, namely, lymphomas, namely, Hodgkin's disease and non-Hodgkin lymphomas, lymphadenopathy, myeloma, namely, multiple myeloma, and leukemia; pharmaceutical and veterinary products for treating haematological diseases, namely, amyloses, and purpura, namely, thrombocytopenic purpura; pills, capsules, tablets, and powders pertaining to healthy diet for use in treating oncological diseases; chemical preparations for medical and pharmaceutical use for treating progression of chronic diseases, proliferative disease, and for treating rheumatological diseases; chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, colon cancer, rectum cancer, breast cancer, prostate cancer, pancreatic cancer, gastric cancer, thyroid cancer, larynx cancer, liver cancer, uterine cancer, cervical cancer, esophagus cancer, ovarian cancer, lung cancer, pleural cancer, oral cavity cancer, kidney cancer, bladder cancer, testicular cancer, melanoma, lymphatic cancer, hematopoietic cancer, carcinoma, sarcoma, nervous system cancer, namely, primary tumors; chemical preparations for medical and pharmaceutical use for treating onco-haematological diseases, namely, lymphomas, namely, Hodgkin's disease and non-Hodgkin lymphomas, lymphadenopathy, myeloma, namely, multiple myeloma, and leukemia. chemical preparations for medical and pharmaceutical use for treating haematological diseases, namely, amyloses, and purpura, especially thrombocytopenic purpura |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 27, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | LABORATOIRES C.T.R.S. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Boulogne-Billancourt 92100 FR |
| Party Name | LABORATOIRES C.T.R.S. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Boulogne-Billancourt 92100 FR |
| Party Name | LABORATOIRES C.T.R.S. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Boulogne-Billancourt 92100 FR |
| Event Date | Event Description |
| Tuesday, November 1, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 1, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 16, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 16, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 27, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 14, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 13, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 12, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 5, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 5, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 5, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 29, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, October 27, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, October 2, 2021 | NEW APPLICATION ENTERED IN TRAM |